Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients

Cancer patients are considered as highly vulnerable to COVID-19 pandemic. However, delaying cancer specific therapies could have a deleterious effect on survival. The potential suppressive effects of chemotherapies or cancer-related microenvironment raised the question on how cancer patients’ immune system responds to SARS-CoV-2 virus.

Lascia un commento